Mining the potential therapeutic targets for COVID-19 infection in patients with severe burn injuries via bioinformatics analysis

被引:0
|
作者
Cai, Xueyao [1 ]
Deng, Jing [1 ]
Shi, Wenjun [2 ]
Cai, Yuchen [2 ,3 ]
Ma, Zhengzheng [1 ,4 ]
机构
[1] Dongguan Tungwah Hosp, Dept Burn & Plast Surg, Dongguan, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, 639 Zhi Zao-Ju Rd, Shanghai 200011, Peoples R China
[4] Dongguan Tungwah Hosp, Dept Burn & Plast Surg, 1 Dongcheng East Rd, Dongguan 523000, Peoples R China
关键词
COVID-19; differentially expressed genes; hub genes; severe burn; therapy; CELLS;
D O I
10.1111/iwj.14151
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The Coronavirus Disease-19 (COVID-19) pandemic is posing a serious challenge to human health. Burn victims are susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leading to delayed recovery and even profound debilitation. Nevertheless, the molecular mechanisms underlying COVID-19 and severe burn are yet to be elucidated. In our work, the differentially expressed genes (DEGs) were identified from GSE157852 and GSE19743, and the common DEGs between COVID-19 and severe burn were extracted. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), protein-protein interactions (PPI), gene coexpression network, and multifactor regulatory network analysis of hub genes were carried out. A total of 44 common DEGs were found between COVID-19 and severe burn. Functional analyses indicated that the pathways of immune regulation and cytokine response participated collectively in the development of severe burn and progression of COVID-19. Ten significant hub genes were identified, including MERTK, SIRPA, TLR3, ITGB1, DPP4, PTPRC, LY75, IFIT1, IL4R, and CD2. In addition, the gene coexpression network and regulatory network were constructed containing 42 microRNAs (miRNAs) and 2 transcription factors (TFs). Our study showed the shared pathogenic link between COVID-19 and severe burn. The identified common genes and pivotal pathways pave a new road for future mechanistic researches in severe burn injuries complicated with COVID-19.
引用
收藏
页码:2742 / 2752
页数:11
相关论文
共 50 条
  • [31] Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets
    Ruenjaiman, Vichaya
    Hirankarn, Nattiya
    Palaga, Tanapat
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2021, 39 (02) : 69 - 77
  • [32] What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?
    Guterres, Alexandro
    de Azeredo Lima, Carlos Henrique
    Miranda, Renan Lyra
    Gadelha, Monica Roberto
    INFECTION GENETICS AND EVOLUTION, 2020, 85
  • [33] Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)
    Nadeem, Muhammad Shahid
    Zamzami, Mazin A.
    Choudhry, Hani
    Murtaza, Bibi Nazia
    Kazmi, Imran
    Ahmad, Habib
    Shakoori, Abdul Rauf
    PATHOGENS, 2020, 9 (04):
  • [34] Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients
    Tremblay, Douglas
    Seah, Carina
    Schneider, Thomas
    Bhalla, Sheena
    Feld, Jonathan
    Naymagon, Leonard
    Wang, Bo
    Patel, Vaibhav
    Jun, Tomi
    Jandl, Thomas
    Rahman, Farah
    Liu, Sean T. H.
    Aberg, Judith A.
    Bouvier, Nicole
    CANCER MEDICINE, 2020, 9 (22): : 8571 - 8578
  • [35] Bioinformatics and system biology approach to identify potential common pathogenesis for COVID-19 infection and sarcopenia
    Zhong, Jun
    Yuan, Hui
    Yang, Jinghong
    Du, Yimin
    Li, Zheng
    Liu, Xu
    Yang, Haibo
    Wang, Zhaojun
    Wang, Zi
    Jiang, Lujun
    Ren, Zhiqiang
    Li, Hongliang
    Li, Zhong
    Liu, Yanshi
    FRONTIERS IN MEDICINE, 2024, 11
  • [36] Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine
    Ibrahim, Homam
    Perl, Andras
    Smith, Deane
    Lewis, Tyler
    Kon, Zachary
    Goldenberg, Ronald
    Yarta, Kinan
    Staniloae, Cezar
    Williams, Mathew
    CLINICAL IMMUNOLOGY, 2020, 219
  • [37] Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients
    Aliter, Kholoud F.
    Al-Horani, Rami A.
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (06) : 866 - 875
  • [38] Network Pharmacology and Bioinformatics Analyses Identify Intersection Genes of Vitamin D3 and COVID-19 as Potential Therapeutic Targets
    Wang, Shanglin
    Gao, Huayu
    Wang, Xiaoru
    Ma, Xiaoli
    Zhang, Lulu
    Xing, Yuanxin
    Jia, Yanfei
    Wang, Yunshan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [39] Clinical analysis of severe COVID-19 patients
    Wang, Hao
    Sun, Bin
    Li, Xiayuan
    Wang, Yun
    Yang, Zhengping
    TECHNOLOGY AND HEALTH CARE, 2022, 30 : S225 - S234
  • [40] The Potential of Ameliorating COVID-19 and Sequelae From Andrographis paniculata via Bioinformatics
    Nguyen, Hien Thi
    Do, Van Mai
    Phan, Thanh Thuy
    Huynh, Dung Tam Nguyen
    BIOINFORMATICS AND BIOLOGY INSIGHTS, 2023, 17